Safety and efficacy of 90Y-FAPI-46 radioligand therapy in patients with advanced sarcoma and other cancer entities
Wolfgang P Fendler, Kim M Pabst, Lukas Kessler, Pedro Fragoso Costa, Justin Ferdinandus, Manuel Weber, […]
Wolfgang P Fendler, Kim M Pabst, Lukas Kessler, Pedro Fragoso Costa, Justin Ferdinandus, Manuel Weber, […]
Congratulations to investigators at Hannover School of Medicine and Heidelberg University Hospital for receiving the […]

SOFIE hosted a FAP session, together with Clovis […]
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2022 Annual SNMMI Meeting – Vancouver, Canada
June […]
Presented by: Professor Jeremie Calais, MD, MSc, Professor, University of California, Los Angeles
2022 Annual SNMMI […]
SOFIE/Clovis Oncology/POINT Biopharma
Satellite Symposium, 2022 Annual SNMMI Meeting – Vancouver Canada
June 12, 2022 Watch Webinar […]
Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
June 8, 2022 Download the Presentation […]
Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, […]
Dulles, VA, April 27, 2022– SOFIE Co. (SOFIE), a Theranostics company, commissions its new […]
Umut Elboga, Ertan Sahin, Tulay Kus, Yusuf Burak Cayirli, Gokmen Aktas, Merve […]